Correlation Between Vertex Pharmaceuticals and ATRYS HEALTH

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and ATRYS HEALTH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and ATRYS HEALTH into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and ATRYS HEALTH SA, you can compare the effects of market volatilities on Vertex Pharmaceuticals and ATRYS HEALTH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of ATRYS HEALTH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and ATRYS HEALTH.

Diversification Opportunities for Vertex Pharmaceuticals and ATRYS HEALTH

-0.27

Correlation Coefficient

Vertex Pharmaceuticals  ATRYS HEALTH

Very good diversification

The 3 months correlation between Vertex and ATRYS is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and ATRYS HEALTH SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATRYS HEALTH SA and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with ATRYS HEALTH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATRYS HEALTH SA has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and ATRYS HEALTH go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and ATRYS HEALTH

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to generate 0.7 times more return on investment than ATRYS HEALTH. However, Vertex Pharmaceuticals Incorporated is 1.42 times less risky than ATRYS HEALTH. It trades about 0.05 of its potential returns per unit of risk. ATRYS HEALTH SA is currently generating about -0.04 per unit of risk. If you would invest  27,215  in Vertex Pharmaceuticals Incorporated on September 26, 2024 and sell it today you would earn a total of  11,085  from holding Vertex Pharmaceuticals Incorporated or generate 40.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vertex Pharmaceuticals Incorpo  vs.  ATRYS HEALTH SA

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

ATRYS HEALTH SA

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Vertex Pharmaceuticals and ATRYS HEALTH

The main advantage of trading using opposite Vertex Pharmaceuticals and ATRYS HEALTH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, ATRYS HEALTH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATRYS HEALTH will offset losses from the drop in ATRYS HEALTH's long position.

The idea behind Vertex Pharmaceuticals Incorporated and ATRYS HEALTH SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.